Innovative inhaler: the Novolizer
On the global market
The Novolizer is now on sale on the global market and the number of asthma and COPD drugs for which it can be used will soon be increased. Various pharmaceutical companies are involved in its further development. In addition, De Boer and Frijlink and their team of specialists are currently working on a special disposable inhaler (the Twincer) for administering drugs for conditions such as cystic fibrosis and tuberculosis. The pharmaceutical industry is already keenly anticipating this new inhaler, as it is also suitable for administering flu jabs and vaccinations against various other infectious diseases. It is thought that the Twincer will be available for use by patients in just a few years.
On 21 April 2010, Anne de Boer and Erik Frijlink were awarded the Wubbo Ockels prize for the successful development of this innovative Novolizer inhaler.
Last modified: | 22 August 2024 1.32 p.m. |
More news
-
17 June 2025
ERC Advanced grants for three UG researchers
The European Research Council has awarded ERC Advanced grants to Prof. Inga Kamp, Prof. Wouter Roos and Prof. Syuzanna Harutyunyan.
-
13 June 2025
Team 'Lord of the Roads' second at RDW Self Driving Challenge
The University of the North team 'Lord of the Roads', in which students from educational institutions Noorderpoort, Hanzehogeschool and the University of Groningen collaborated, came second in the RDW Self Driving Challenge (SDC). The team competed...
-
12 June 2025
Those most affected by modern agriculture
Farmers only grow a limited number of crops these days, which has significant consequences for the animals that live there. Raymond Klaassen researches what adjustments farmers could make to improve the conditions for the species most affected by...